Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Aphria Inc. APHA

Healthcare Drug Manufacturers - Major Cannabis
Aphria, which is headquartered in Ontario, produces and sells medicinal and recreational cannabis. The company operates through retail and wholesale channels in Canada and internationally. Aphria is a main distributor of medical cannabis to Germany and has operations in over 10 countries outside of Canada. However, it does not have exposure to the U.S. CBD or THC markets due to the constraints of federal prohibition. It has some U.S. exposure through the acquisition of SweetWater, a craft brewer


NDAQ:APHA - Post by User

Aphria Inc.
Bullboard Posts
User Avatar Image
(1)
•••
Comment by Viking49on Jun 08, 2018 11:45am
51 Views
Post# 28146148

RE:RE:RE:RE:The popular BlueDream as a VAP cartridge from Aphria!

RE:RE:RE:RE:The popular BlueDream as a VAP cartridge from Aphria!
GiddeeeUp wrote: MA, my take is it can process that much so that would be input. Haven't read anything on conversion rates of KGs of cannabis to KGs of distillates.
This from a news article: 'The facility will house two Class 1 extraction rooms capable of processing more than 200,000 kilograms of cannabis annually. ' G


Science will dictate inputs and outputs.

With a 20-21% THC strain, 5 grams is required to extract 1 gram of concentrate.

With a 16-17% THC strain, 6 grams is required to extract 1 gram of concentrate.

Treasure Island is about 17% CBD so 6 grams will be needed for 1 gram concentrate.

LHS today is retailing 1 gram of concentrate for $120 US.  

Assume wholesale prices of 50% of retail.

Crunch the numbers and you have $2 BILLION plus of potential wholesale revenues that would be output on an annual basis from the extraction facility! A world class facility in a new rapidly expanding market!  

Aphria is not playing checkers, they are playing 3D chess! Thinking many moves ahead!  There are many pie in sky forecasts from all the LPs in this sector and there has been a lot more hype than execution.  Aphria has demonstrated execution and profitability to date and will continue to do so!

I will wait for financials to provide the validation.........and turn off the noise!


Bullboard Posts
Dealroom for high-potential pre-IPO opportunities